Bruker Corporation (Nasdaq: BRKR) today announced new advancements to enable Functional Proteomics 2.0 workflows on the ...
Explore technical features and comparative strengths of MaxQuant, Proteome Discoverer, FragPipe, and DIA-NN workflows.
This article takes a deep dive into the history of proteomics from the conception of the term “proteome” up to modern-day advances in bioinformatics and single-cell protein analysis.
All biological function is dependent on how different proteins interact with each other. Protein-protein interactions ...
Hundreds of protein-ligand interactions have been identified through a collaboration between the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences and Pfizer. Georg ...
Fragment-based drug design (FBDD) has led to a revolution in contemporary drug discovery, facilitating a bottom-up approach to the identification and evolution of bioactive small molecules into viable ...